Predicate |
Object |
contentType |
Journal Article |
endingPage |
1271 |
issn |
1948-5875 |
issueIdentifier |
12 |
pageRange |
1270-1271 |
publicationName |
ACS Medicinal Chemistry Letters |
startingPage |
1270 |
bibliographicCitation |
Abdel-Magid AF. Inhibition of O-GlcNAcase (OGA): A Potential Therapeutic Target to Treat Alzheimer's Disease. ACS Med Chem Lett. 2014 Dec 11;5(12):1270–1. PMID: 25516783; PMCID: PMC4265821. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2536b061f4fa620b7f2922179c1028f6 |
date |
2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1021/ml500450c https://pubmed.ncbi.nlm.nih.gov/25516783 https://pubmed.ncbi.nlm.nih.gov/PMC4265821 |
isPartOf |
https://portal.issn.org/resource/ISSN/1948-5875 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37641 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Inhibition of O-GlcNAcase (OGA): A Potential Therapeutic Target to Treat Alzheimer’s Disease |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.2.1.169 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9989f979b8b448112f1dfe6a2fdab8a2 |